Evidence map›Paper›PMID 18511652›Full record

ArticleMolecular pharmacology2008

Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers.

Adebowale Adebiyi, Elizabeth M McNally, Jonathan H Jaggar

Abstract read
In one paragraph

Article in Molecular pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The expression of KAnnals of translational medicine · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Vasodilation induced by oxygen/glucose deprivation is attenuated in cerebral arteries of SUR2 null mice.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  15. Hydrogen sulfide dilates cerebral arterioles by activating smooth muscle cell plasma membrane KATP channels.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  16. Article
  17. Article
  18. Hydrogen sulfide and cerebral microvascular tone in newborn pigs.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Adebowale AdebiyiDepartment of Physiology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Elizabeth M McNally
Jonathan H Jaggar
University of Tennessee Health Science Center · USUniversity of Chicago · US

Funding

Vascular control by K+ channel traffickingR01HL067061 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JAGGAR, JONATHAN H · 2002 to 2016
$4.8M
Sulfonylurea KATP channels in vascular spasmR01HL078926 · NHLBI · UNIVERSITY OF CHICAGO · PI MCNALLY, ELIZABETH M · 2005 to 2009
$1.8M
Mitochondrial regulation of calcium signalingR01HL077678 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JAGGAR, JONATHAN H · 2005 to 2008
$1.3M
NHLBI NIH HHS R01 HL067061NHLBI NIH HHS R01 HL077678NHLBI NIH HHS R01 HL078926
6 · The paper itself

Abstract

ATP-sensitive K+ (KATP) channel openers are vasodilators that activate both plasma membrane and mitochondrial KATP channels. Here, we investigated the molecular mechanisms by which diazoxide and pinacidil induce vasodilation by studying diameter regulation of wild-type [SUR2(+/+)] and sulfonylurea receptor (SUR) 2-deficient [SUR2(-/-)] mouse myogenic mesenteric arteries. Ryanodine (10 microM), a ryanodine-sensitive Ca2+ release (RyR) channel blocker; iberiotoxin (100 nM), a large-conductance Ca2+-activated K+ (KCa) channel blocker; 4-aminopyridine (4-AP; 1 mM), a voltage-gated K+ (KV) channel blocker; manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP; 100 microM), an antioxidant; and a combination of ryanodine and 4-AP reduced diazoxide (100 microM)-induced dilation in pressurized (60 mm Hg) SUR2(+/+) arteries by 45 to 77%. In contrast, these inhibitors did not alter pinacidil (5 microM)-induced dilation in SUR2(+/+) arteries. Reverse transcription-polymerase chain reaction indicated that SUR2B was the only SUR isoform expressed in SUR2(+/+) mesenteric artery smooth muscle cells, whereas SURs were absent in SUR2(-/-) cells. In SUR2(-/-) arteries, pinacidil-induced vasodilation was 10% of that in SUR2(+/+) arteries, whereas diazoxide-induced vasodilation was similar in SUR2(+/+) and SUR2(-/-) arteries. Atpenin (1 microM), a selective electron transport chain (ETC) complex II inhibitor, dilated arteries similarly to diazoxide, and this effect was attenuated by MnTMPyP and ryanodine + 4-AP. Atpenin also attenuated diazoxide-, but not pinacidil-induced vasodilation. In summary, data indicate that pinacidil-induced vasodilation requires SUR2B, whereas diazoxide-induced vasodilation does not require SURs. Rather, diazoxide-induced vasodilation involves ETCII inhibition; a smooth muscle cell-reactive oxygen species elevation; and RyR, KCa, and KV channel activation. These data indicate that KATP channel openers regulate arterial diameter via SUR-dependent and -independent pathways.

Indexed as

Adenosine TriphosphateAnimalsATP-Binding Cassette TransportersBlood PressureDiazoxideElectron Transport Complex IIEndotheliumIn Vitro TechniquesIon Channel GatingMembrane Transport ModulatorsMesenteric ArteriesMiceMuscle CellsPinacidilPotassium ChannelsPotassium Channels, Inwardly RectifyingAbcc9 protein, mouseAdenosine TriphosphateATP-Binding Cassette TransportersDiazoxideElectron Transport Complex IIMembrane Transport ModulatorsPinacidilPotassium ChannelsPotassium Channels, Inwardly RectifyingProtein SubunitsReceptors, DrugRyanodine Receptor Calcium Release ChannelSulfonylurea Receptors

Identifiers

PMID18511652
PMCPMC2613800
OpenAlexW2169262761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.